Pluri Inc.

Director's Dealing • Jul 2, 2025

FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0287
Estimated average burden hours per response	0.5

Manieu Alexandre Weinstein	1. Name and Address of Reporting Person	*	2. Issuer Name and Ticker or Trading Symbol Pluri Inc. [ PLUR ]		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
				X	Director	X	10% Owner
(Last)	(First)	(Middle)			Officer (give title below)		Other (specify below)
RESORT, BURGENSTOCK 30	APT 8002, BURGENSTOCK HOTELS &		3. Date of Earliest Transaction (Month/Day/Year) 04/28/2025
(Street)			4. If Amendment, Date of Original Filed (Month/Day/Year)				6. Individual or Joint/Group Filing (Check Applicable Line)
OBBURGEN	V8	6363		X	Form filed by One Reporting Person		Form filed by More than One Reporting Person
(City)	(State)	(Zip)

	Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership
			Code	V	Amount	(A) or (D)	Price	Transaction(s) (Instr. 3 and 4)		(Instr. 4)
Common Stock								10,250	D
Common Stock	04/28/2025		P		523,437	A	\$4.61	931,246	I	Shares indirectly held through Chutzpah Holdings (1) Limited
Common Stock	04/28/2025		P		452,702	A	\$4.61	452,702	I	Shares indirectly held through Plantae Bioscience (2) Ltd.
Common Stock	04/28/2025		J		(4) 976,139	D	(4)	931,246	I	Shares indirectly held through Chutzpah Holdings (1) Limited

						Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying 3 and 4)	Derivative Security (Instr.	8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following	10. Ownership Form: Direct (D) or Indirect (I) (Instr.	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares		Reported Transaction(s) (Instr. 4)	4)

plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction

10.

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See

Pre Funded Warrants to \$0.0001 04/28/2025 purchase Common Shares	J	(4) 976,139	(3)	(3)	Common Shares	976,139	(4)	976,139	I	Indirectly held through Chutzpah Holdings (1) Limited
* 1. Name and Address of Reporting Person Manieu Alexandre Weinstein	10% Owner Director
(Last) (First) (Middle) APT 8002, BURGENSTOCK HOTELS & RESORT, BURGENSTOCK 30
(Street)
OBBURGEN V8 6363
(City) (State) (Zip)
* 1. Name and Address of Reporting Person Chutzpah Holdings Ltd	Director
(Last) (First) (Middle)
4TH FLOOR, LIBERATION HOUSE CASTLE STREET
(Street)
ST HELIER Y9 JE1 4HH
(City) (State) (Zip)

Explanation of Responses:

1. This statement is jointly filed by and on behalf of each of Chutzpah Holdings Limited ("Chutzpah") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah. Each reporting person (i) states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement; (ii) disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities; and (iii) declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

2. Mr. Weinstein indirectly owns 77% of Plantae Bioscience Ltd. ("Plantae") and may be deemed to beneficially own securities owned by Plantae. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by Plantae. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

3. The Pre-Funded Warrants are exercisable at any time following the receipt of certain approvals from Pluri Inc.'s (the "Company") shareholders required by the applicable rules of the Nasdaq Capital Market, and remain exercisable until exercised in full.

4. On April 25, 2025, the Company entered into an amendment (the "Amendment") to its previously executed Securities Purchase Agreement, entered into on January 23, 2025 by the Company and Chutzpah. Pursuant to the Amendment, the Company and Chutzpah agreed to exchange 976,139 Common Shares for pre-funded warrants to purchase up to 976,139 Common Shares.

Remarks:

Exhibit Index: Exhibit 99.1 - Joint Filer Information (incorporated by reference to Exhibit 99.1 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Exhibit 99.2 - Joint Filing Agreement (incorporated by reference to Exhibit 99.2 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025).

/s/ Alexandre Weinstein Manieu	07/01/2025
** Signature of Reporting Person	Date
/s/ Ana Ventura Authorized Officer For
Beaumont (Directors) Limited Sole Corporate	07/01/2025
Director
** Signature of Reporting Person	Date
/s/ Karen Oliver Authorized Officer For
Beaumont (Directors) Limited Sole Corporate	07/01/2025
Director

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.